Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals.
نویسندگان
چکیده
Phototoxic properties of systemically applied pharmaceuticals may be the cause of serious adverse drug reactions. Therefore, a reliable preclinical photosafety assessment strategy, combining in vitro and in vivo approaches in a quantitative manner, is important and has not been described so far. Here, we report the establishment of an optimized modified murine local lymph node assay (LLNA), adapted for phototoxicity assessment of systemically applied compounds, as well as the test results for 34 drug candidates in this in vivo photo-LLNA. The drug candidates were selected based on their ability to absorb ultraviolet/visible light and the photo irritation factors (PIFs) determined in the well-established in vitro 3T3 neutral red uptake phototoxicity test. An in vivo phototoxic potential was identified for 13 of these drug candidates. The use of multiple dose levels in the described murine in vivo phototoxicity studies enabled the establishment of no- and/or lowest-observed-adverse-effect levels (NOAELs/LOAELs), also supporting human photosafety assessment. An in vitro-in vivo correlation demonstrated that a drug candidate classified as "phototoxic" in vitro is not necessarily phototoxic in vivo. However, the probability for a drug candidate to cause phototoxicity in vivo clearly correlated with the magnitude of the phototoxicity identified in vitro.
منابع مشابه
Phototoxicity – from molecular descriptors to classification models
Potential photoactivation of certain pharmaceuticals, cosmetic ingredients and natural products by sunlight (e.g., phenothiazines, arylsulfonamides, or coumarins) has to be considered early on in development in order to avoid serious adverse effects (for example phototoxic or photoallergic reactions). Current clinical trial registration guidelines (FDA May 2003 [1], EMEA Dec. 2002 [2]) recommen...
متن کاملAn in vitro model of chemotherapeutic damage to mesenchymal stem cells
s of the 33 Annual Meeting of the United Kingdom Environmental Mutagen Society, 12 14 July 2010 at the University of Derby, UK. 1. Photogenotoxicity – science without application? Daniel Bauer Novartis Institutes of BioMedical Research, Preclinical Safety, 4002 Basel, Switzerland In 1999 the International Workshop on Genotoxicity Test Procedures prepared recommendations for photogenotoxicity te...
متن کاملDevelopment and characterization of an in vivo skin photomicronucleus assay in rats.
For pharmaceuticals, current regulatory guidance for photosafety testing states that studies are warranted for drug candidates that both absorb light in the range of 290-700 nm and that are either applied topically or reach the skin or eyes by systemic exposure. In contrast to standard genotoxicity evaluations, where a positive (or equivocal) result in vitro can be placed into context with addi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Toxicological sciences : an official journal of the Society of Toxicology
دوره 139 1 شماره
صفحات -
تاریخ انتشار 2014